FDA Update on Heater-Cooler Devices

The FDA cleared a heater-cooler system that utilizes a glycol-based heat transfer fluid, instead of water, to help mitigate NTM infections.

If your email program has trouble displaying this email, view as a webpage. Update on Heater-Cooler Devices The U.S. Food and Drug Administration (FDA) is providing updated information about heater-cooler devices used during surgeries to warm or cool patients as part of their care. Through ongoing efforts by the FDA and industry to bring to market innovative devices that can help mitigate the risk of Nontuberculous mycobacteria (NTM) infections, the FDA has cleared a system that utilizes a glycol-based heat transfer fluid (HTF) instead of water. Read More The FDA continues to: monitor the risk of NTM infections in patients who have undergone cardiothoracic surgery using water-based heater-cooler devices. encourage health care providers and users to report any adverse events or suspected adverse events experienced with any heater-cooler devices, including patient infection, device contamination, or difficulty following manufacturer instructions for use. engage with manufacturers, health care facilities, and public health experts in evaluating new design features for heater-cooler devices. Questions? If you have questions Heater-Cooler Devices, contact the Division of Industry and Consumer Education.

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA